Gumanding, Banisa B.
HRN: 29-08-25 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2026
CEFUROXIME 500MG (TAB)
05/31/2026
06/06/2026
PO
500mg
BID
UTI Following Delivery
Checking Initial Appropriateness